Authors: Rosani Sri Camelia Nurdin, Widyawati Djamaluddin, Sri Vitayani, Anni Adriani, Dirmawati Kadir, Safruddin Amin


Introduction: Leprosy is chronicle infectious disease on humans caused by Mycobacterium leprae that mainly attack the peripheral nerve vessels and skin. Leprosy with the highest frequency attacks people within the range of age 25-35 years old. There is no distinction susceptibility among male and female. Bacteria caused this leprosy, Mycobacterium leprae, is obligate aerob intracellular bacteria which cannot be bred in vitro, shaped in 3 – 8 μm x 0,5 μm positive-gram basil. It is acid and alcohol resistant.

Case Summary: It was reported that there is lepromatous leprosy on a 22-year old man with reddish patches on the face and white patches on the chest and back clinical symptoms together with wound and thickened left eye. Basil Acid Resistant ( BAR) examination shows +3 on the tip of right – left lobes and +1 on lesion at the back. Histopathology examination shows that the lepromatous leprosy therapy given is Multi Drugs Therapy ( MDT) MB and neuroborant.

Conclusion: Lepromatous leprosy diagnosis enforced to this patient is based on anamnesis, Basil Acid Resistant (BAR) examination and histopathology examination. The main objective of the leprosy therapy is to stop the chains transmission in order to lower the disease incident, treat and cure the patient, prevent the disease. In order to achieve these goals, basic strategy needs to be done based on early detection and treatment. It is suggested in for leprosy treatment to use Multi Drugs Therapy (MDT) program, recommended by WHO. The program includes rifampicin combination, clofazimine and diamino diphenyl sulphone.





Leprosy, lepromatous leprosy, mycobacterium leprae



More Articles


/* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Conditionally display Abstract button ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ */ /* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Conditionally display References button ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ */